Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypothesize that germline polymorphisms might be associated with clinical outcome.status: publishe
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify c...
Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypothesize...
Purpose: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Purpose: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Item does not contain fulltextPURPOSE: Chemotherapy resistance remains a major challenge in the trea...
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
PurposeChemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypo...
PurposeChemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypo...
Ovarian cancer remains a significant public health burden, with the highest mortality rate of all th...
Ovarian cancer remains a significant public health burden, with the highest mortality rate of all th...
Ovarian cancer remains a significant public health burden, with the highest mortality rate of all th...
<div><p>Background</p><p>Ovarian cancer remains a significant public health burden, with the highest...
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify c...
Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypothesize...
Purpose: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Purpose: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Item does not contain fulltextPURPOSE: Chemotherapy resistance remains a major challenge in the trea...
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
PurposeChemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypo...
PurposeChemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypo...
Ovarian cancer remains a significant public health burden, with the highest mortality rate of all th...
Ovarian cancer remains a significant public health burden, with the highest mortality rate of all th...
Ovarian cancer remains a significant public health burden, with the highest mortality rate of all th...
<div><p>Background</p><p>Ovarian cancer remains a significant public health burden, with the highest...
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify c...